logo
GaldermaExpandsRestylanePortfolioinJapanWithLaunchofOBTHyaluronicAcidInjectablesRestylaneDefyneandRefyne
===2026/2/11 14:29:40===
the region.”



HON KEONG CHOO

HEAD OF JPAC REGION

GALDERMA










With over 30 years of innovation and more than 77 million treatments administered worldwide, Restylane is highly relevant in addressing some of today’s most significant aesthetic trends and needs, from improving facial harmony following medication-driven weight loss to growing concerns around menopause-related skin health and aging.5,14-17The arrival of OBT technology in Japan now aligns the market more closely with global Restylane availability, reinforcing the brand’s position as the world’s most scientifically studied and diverse hyaluronic acid injectables range.

About the Restylane portfolio
Restylane hyaluronic acid treatments are designed differently to go beyond volumizing for natural-looking results.4,5,18,19Our hyaluronic ac
=*=*=*=*=*=
当前为第5/11页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页